Detalles de la búsqueda
1.
Novel Supreme Drug-Eluting Stents With Early Synchronized Antiproliferative Drug Delivery to Inhibit Smooth Muscle Cell Proliferation After Drug-Eluting Stents Implantation in Coronary Artery Disease: Results of the PIONEER III Randomized Clinical Trial.
Circulation
; 143(22): 2143-2154, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33820424
2.
Effect of platelet inhibition with cangrelor during PCI on ischemic events.
N Engl J Med
; 368(14): 1303-13, 2013 Apr 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-23473369
3.
Are adverse events following an invasive strategy in patients with non-ST-segment elevation acute coronary syndromes more frequent at US sites versus non-US sites? Analysis from the ACUITY trial.
Catheter Cardiovasc Interv
; 82(4): E365-74, 2013 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22887494
4.
Predictive value of C-reactive protein on 30-day and 1-year mortality in acute coronary syndromes: an analysis from the ACUITY trial.
J Thromb Thrombolysis
; 31(2): 154-64, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-20953817
5.
Early stent thrombosis in patients with acute coronary syndromes treated with drug-eluting and bare metal stents: the Acute Catheterization and Urgent Intervention Triage Strategy trial.
Circulation
; 119(5): 687-98, 2009 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-19171852
6.
One-Month Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention With Zotarolimus-Eluting Stents in High-Bleeding-Risk Patients.
Circ Cardiovasc Interv
; 13(11): e009565, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33167705
7.
Global Approach to High Bleeding Risk Patients With Polymer-Free Drug-Coated Coronary Stents: The LF II Study.
Circ Cardiovasc Interv
; 13(4): e008603, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32279567
8.
Bivalirudin for patients with acute coronary syndromes.
N Engl J Med
; 355(21): 2203-16, 2006 Nov 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-17124018
9.
Outcomes of patients with coronary artery perforation complicating percutaneous coronary intervention and correlations with the type of adjunctive antithrombotic therapy: pooled analysis from REPLACE-2, ACUITY, and HORIZONS-AMI trials.
J Interv Cardiol
; 22(5): 453-9, 2009 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-19702677
10.
Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial.
Lancet
; 369(9565): 907-19, 2007 Mar 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-17368152
11.
Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trial.
JAMA
; 298(21): 2497-506, 2007 Dec 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-18056903
12.
Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trial.
JAMA
; 297(6): 591-602, 2007 Feb 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-17299194
13.
First Report of the Resolute Onyx 2.0-mm Zotarolimus-Eluting Stent for the Treatment of Coronary Lesions With Very Small Reference Vessel Diameter.
JACC Cardiovasc Interv
; 10(14): 1381-1388, 2017 07 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-28728650
14.
One-Month Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention With Zotarolimus-Eluting Stents in High-Bleeding-Risk Patients
Circ., cariovasc. interv. (Print)
; 13(11): 222-232, Nov. 2020. tab, graf
Artículo
en Inglés
| CONASS, SES-SP, SESSP-IDPCPROD, SES-SP | ID: biblio-1150552
15.
Normokinesia adjacent to left ventricular aneurysm: a differential risk for sudden cardiac death.
Eur J Heart Fail
; 4(1): 33-40, 2002 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-11812663
16.
Bleeding risk factors affecting warfarin therapy in the elderly with atrial fibrillation.
Dimens Crit Care Nurs
; 33(2): 57-63, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24496251
17.
Implications of pre-procedural TIMI flow in patients with non ST-segment elevation acute coronary syndromes undergoing percutaneous coronary revascularization: insights from the ACUITY trial.
Int J Cardiol
; 167(3): 727-32, 2013 Aug 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-22464479
18.
Quantification of the effect of clopidogrel on enzymatic infarct size related to a percutaneous coronary intervention in patients with acute coronary syndromes: insights from the CHAMPION percutaneous coronary intervention trial.
Coron Artery Dis
; 24(4): 321-7, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23442944
19.
Outcomes of patients with prior coronary artery bypass grafting and acute coronary syndromes: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial.
JACC Cardiovasc Interv
; 5(9): 919-26, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22995879
20.
Impact of femoral vascular closure devices and antithrombotic therapy on access site bleeding in acute coronary syndromes: The Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial.
Circ Cardiovasc Interv
; 3(1): 57-62, 2010 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20118151